MYH9 and neoplasm: This disengages MYH9 from the cytoskeleton and increases its nuclear levels in EOC cells, which facilitates the transcriptional regulation of CTNNB1 and activation of Wnt/β‐catenin signaling and thereby induces tumor stemness and platinum resistance.